Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Cadbury Schweppes

7 Mar 2005 07:00

Embargoed Release: 07:00 hrs Monday 7th March 2005 SOPHEON PLC (`Sopheon' or `the Company') Product Innovation Focus Prompts Cadbury Schweppes to Deploy Sopheon Portfolio and Process Management System Food and Beverage Leader Implements Accolade Enterprise-wide to Support Integrated Portfolio Management, Increase Revenue from New Products Sopheon, the international software and services company, announced today thatCadbury Schweppes, a leading global confectionary and beverage company, hasselected Sopheon's Accolade portfolio and process management system to enhancea company-wide integrated portfolio management initiative aimed at increasinggrowth from innovation. The Accolade deployment spans 45 countries and includes2,400 users in product development, marketing and commercial strategy. Itencompasses all five of Cadbury's operating regions, specifically AmericasBeverages; Americas Confectionery; Europe, Middle East and Africa; EuropeanBeverages; and Asia Pacific.One of the largest international confectionery and beverage companies in theworld, Cadbury Schweppes employs well over 50,000 people and has an impressivelist of popular brand name products, including Cadbury, Schweppes, Halls,Trident, Dr Pepper, Snapple, Trebor and Dentyne. Sopheon's Accolade will beused both to support product portfolio management and to automate and managethe company's implementation of Stage-Gate, a widely-used product developmentprocess methodology. The software system will serve as a central repository forproduct information within business units and across the company. Accolade waschosen because of its ease-of-use, speed and ease of deployment, comprehensiveportfolio decision-support capabilities and overall cost-effectiveness."Cadbury Schweppes' stature as a leading innovator reaches back over 200years," said Christine Connelly, chief information officer at CadburySchweppes. "We are determined that this commitment to innovation will be asmuch a part of our future as it has been our past. To maintain ourmarket-leading position, we have outlined an organic growth strategy thatrelies upon our ability to innovate well and achieve high levels of return onour innovation investments. Sopheon's Accolade will give us the processuniformity and performance consistency we need to enable the sharing ofknowledge and expertise across a common process and system platform, ensuringfaster time-to-market with winning products.""The list of `most admired' companies adopting Sopheon's Accolade systemcontinues to grow," said Mike Connolly, Sopheon's director of sales in the U.K."Cadbury Schweppes is an industry vanguard with a clear vision of what it takesto drive innovation across geographies, organizational and functionalboundaries, and product categories to sustain business success. The company'sdecision to deploy Accolade reflects and affirms our solution's capacity tohandle the critical and unique product-portfolio and process-management needsof food and beverage manufacturers. We are delighted by the opportunity topartner with Cadbury Schweppes in the pursuit of its innovation and businessgoals."Sopheon Accolade‚® is a registered trademark of Sopheon plc.All other trademarks and registered trademarks are the soleproperty of their respective owners.About Cadbury SchweppesCadbury Schweppes (LSE: CBRY) is a major global group which manufactures,markets and distributes branded confectionery and beverage products around theworld. With origins stretching back over 200 years, today Cadbury Schweppes'products-which include brands such as Cadbury, Schweppes, Halls, Trident, DrPepper, Snapple, Trebor, Dentyne, Bubblicious and Bassett-are enjoyed in almostevery country around the world. In 2004, Cadbury Schweppes was voted Britain'smost admired company by its peers. It is number one in sugar and functionalconfectionery, a strong number two in gum and the world's third-largest softdrinks group. For more information, please visit www.cadburyschweppes.com.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevantcontent to healthcare and engineering professionals to enable effectivecompliance with protocols, standards and regulations. Sopheon is listed on theAIM Market of the London Stock Exchange and on the Euronext in the Netherlands.For more information, please visit www.sopheon.com. # # # For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010END
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.